The pharmaceutical bets of Jefferies are the laboratories of Divi and 3 Smallcaps, with a maximum of 30% advantage. This is why

The CRDMO sector of India will benefit from the steel wind that can stimulate growth in its growth for the next 3-5 years, the global brokerage Jefferies said in a note because it opted for four shares from the sector for profit up to 30%. After 50 investor meetings where American brokerage, the recommendations were […]

Cohans Lifesciences and other pharmaceutical shares jump to 5% after Jefferies initiates buy recommendation

Shares of CoHance Lifesciences rose by 5.5% to RS 935 in Intraday trade after Jefferies had initiated cover with a ‘buy’ rating and a target price of RS 1.150. The global brokerage expressed a bullish look at selected Indian pharmaceutical and CRDMO companies, which assign ‘buy’ assessments to CoHance Lifesciences, Divi’s Laboratories and Sai Life […]